3 Best Stocks for Investing in Generic Drugs
Keith Speights, The Motley Fool - Motley Fool - Sat Apr 25, 11:02AM CDT
Source: FoolEditorial on Flickr. Americans spent more on prescription drugs last year than ever before -- nearly $374 billion, according to IMS Health . That figure reflected a 13.1% jump over 2013 spending. Health insurers and government...
MNK: 122.01 (-2.84), ACT: 295.41 (-2.95), AKRX: 55.24 (-0.68)
EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims Against Akorn, Inc.
Business Wire - Fri Apr 24, 6:19PM CDT
The Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of investors of Akorn, Inc. (NASDAQ:AKRX) resulting from allegations that Akorn may have issued materially misleading business information to the investing public.
AKRX: 55.24 (-0.68)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline - AKRX
PR Newswire - Fri Apr 24, 5:12PM CDT
Pomerantz LLP has filed a class action lawsuit against Akorn, Inc. ("Akorn" or the "Company"
AKRX: 55.24 (-0.68)
After Hours Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Apr 24, 4:37PM CDT
VRSN: 65.04 (-2.69), MXWL: 6.33 (-0.85), UEC: 2.31 (-0.09), MRVL: 14.31 (-0.22), VALE: 7.92 (+0.80), AKRX: 55.24 (-0.68), WTW: 8.25 (+0.15), CDE: 5.17 (-0.39), EJ: 6.52 (-0.23), SIMO: 30.40 (-2.75)
Akron Will Restate Earnings; Drug Stock Tumbles
at Investor's Business Daily - Fri Apr 24, 4:16PM CDT
Akron (AKRX) late Friday said it would have to restate its 2014 financials, estimating that it overstated revenue and pre-tax income from continuing operations by $20 million to $35 million. Akron shares fell 14.4% to 47.28 in after-hours action....
AKRX: 55.24 (-0.68)
Stocks Finish Solid Week; Akorn Restates 2014 Revenue
at Investor's Business Daily - Fri Apr 24, 3:55PM CDT
Stocks settled back slightly going into the close Friday, but managed to hold most of the day's gains despite weakness in chip stocks. But after the close, leading drugmaker Akorn (AKRX) dropped sharply. It announced it had preliminarily discovered...
SBUX: 51.84 (+2.41), BIIB: 401.71 (-28.57), CAVM: 65.63 (-4.51), AMZN: 445.10 (+55.11), MTSI: 31.41 (-1.92), AKRX: 55.24 (-0.68), TXN: 54.73 (+0.01), SKX: 89.66 (+2.79), DPZ: 113.96 (+4.73), GOOGL: 573.66 (+16.20), MSFT: 47.87 (+4.53), AVGO: 119.50 (-4.57)
Akorn to restate financial statements; shares drop after hours
Seeking Alpha - at Seeking Alpha - Fri Apr 24, 3:49PM CDT
AKRX: 55.24 (-0.68)
Akorn Appoints Terry Rappuhn to Board of Directors
GlobeNewswire - Fri Apr 24, 3:10PM CDT
Akorn, Inc. (Nasdaq:AKRX) today announced the appointment of Terry Allison Rappuhn to its Board of Directors and the Board's Audit Committee, effective immediately. In her accomplished career spanning over three decades working with and for public corporations, Ms. Rappuhn has helped rapidly growing companies build infrastructure, processes and teams during periods of transition.
AKRX: 55.24 (-0.68)
Akorn to Make Additional Financial Restatements
GlobeNewswire - Fri Apr 24, 3:05PM CDT
Akorn, Inc. (Nasdaq:AKRX) today announced that it will restate its previously issued financial statements for the annual period ending December 31, 2014 and the quarterly periods ending June 30, 2014, September 30, 2014 and December 31, 2014 due to errors identified during the first quarter 2015 financial review process.
AKRX: 55.24 (-0.68)
'Non-Cyclical Consumer Healthcare': How This Sector Will Create Long-Term Wealth
Peter Mantas - Seeking Alpha - Fri Apr 24, 1:39PM CDT
Allow me to provide you with a hypothetical portfolio containing only 5 stocks. This portfolio is somewhat diversified in that each company operates in different markets with different threats, competitors and opportunities, but all 5 companies have...
MCK: 229.20 (+0.09), AKRX: 55.24 (-0.68), PFE: 35.27 (-0.09), EW: 138.33 (-3.59), LLY: 71.58 (-0.82), GSK: 46.59 (+0.28), MOH: 63.85 (-0.13), ORCL: 43.08 (-0.31), CNC: 73.67 (+1.13), JNJ: 101.08 (+0.62), ANTM: 154.28 (+0.08), VRSK: 72.68 (+0.20), GILD: 103.69 (-1.52), RMD: 65.70 (-7.68), MRK: 57.60 (+0.09), AZN: 71.79 (-1.34), FICO: 93.85 (+0.55), WCN: 46.52 (+0.32), SRCL: 136.94 (-3.56), SNY: 51.75 (-0.01), ACN: 93.40 (-0.44), NVS: 104.28 (-1.22)
Nasdaq Takes Lead In Mixed Open; Microsoft Surges, Biogen Dives
at Investor's Business Daily - Fri Apr 24, 9:35AM CDT
Tech stocks took early control Friday, as the market posted a mixed launch in solid trade. The Nasdaq jumped 0.5%, climbing well into new territory above its 15-year high. The Dow Jones industrial average slipped 0.1%. The S&P 500 added 0.1%, leaving...
BIIB: 401.71 (-28.57), NOAH: 33.79 (+0.63), MMM: 158.99 (-0.67), AMZN: 445.10 (+55.11), NKE: 100.95 (-0.16), AKRX: 55.24 (-0.68), PFE: 35.27 (-0.09), BA: 148.40 (-1.47), MSFT: 47.87 (+4.53)
Nasdaq Hits Record Close; Google, Amazon Rise After Hours
at Investor's Business Daily - Thu Apr 23, 3:50PM CDT
The Nasdaq reached an all-time closing high Thursday, while Google (GOOG) and Amazon.com (AMZN) were higher after hours after issuing Q1 reports. The Nasdaq closed at 5056.06, a 0.4% gain. That edged above the 5048.62 closing high marked 15 years...
BIIB: 401.71 (-28.57), AMZN: 445.10 (+55.11), AKRX: 55.24 (-0.68), DPZ: 113.96 (+4.73), CGNX: 47.50 (-0.78), ULTA: 157.08 (+0.09), GOOG: 565.06 (+18.06)
Nasdaq Nears 2000 Bubble High As Volume Rises
at Investor's Business Daily - Thu Apr 23, 1:58PM CDT
Stocks powered to fresh highs going into the last hour of trading Thursday. Volume picked up with the S&P 500 near a new all-time high and the Nasdaq closing in on the mark it set March 10, 2000, the day the dot-com bubble burst. The Nasdaq was up...
AKRX: 55.24 (-0.68), DPZ: 113.96 (+4.73), CGNX: 47.50 (-0.78), ULTA: 157.08 (+0.09)
Stocks Take A Quiet Step Back; McDonald's, Visa, Tesla Climb
at Investor's Business Daily - Wed Apr 22, 9:38AM CDT
Stocks took mild losses in quiet trading early Wednesday, with earnings reports at the center of the action. The S&P 500 and the Dow Jones industrial average dipped 0.1%. The Nasdaq fell 0.3%. Losses by Boeing (BA), Chipotle Mexican Grill (CMG),...
TSLA: 218.43 (-0.17), AKRX: 55.24 (-0.68), BRCM: 44.46 (-0.98), ILMN: 189.59 (-3.01), BA: 148.40 (-1.47), ISRG: 505.92 (-6.85), V: 67.48 (-0.24), CMG: 637.50 (+1.90), HZNP: 31.75 (+0.97), MCD: 98.74 (+1.74)
Look for Shares of Akorn to Potentially Pullback after Yesterday's 1.34% Rise
Comtex SmarTrend(R) - Tue Apr 21, 5:32PM CDT
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $54.60 to a high of $56.38. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $54.65 on volume of 2.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AKRX: 55.24 (-0.68)
Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Akorn, Inc.
PR Newswire - Tue Apr 21, 4:30PM CDT
Ryan & Maniskas, LLP announces that a class action lawsuit has been filed in United States District Court for the Northern District of Illinois on behalf of all persons or entities that purchased the common stock of Akorn, Inc. ("Akorn" or the "Company"
AKRX: 55.24 (-0.68)
Shares of AKRX Up 14.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Apr 21, 9:41AM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on March 19th, 2015 at $48.53. In approximately 1 month, Akorn has returned 13.97% as of today's recent price of $55.31.
AKRX: 55.24 (-0.68)
Looking For Action? S&P 1500 Most Volatile Stocks
Bespoke Investment Group - at Seeking Alpha - Tue Apr 21, 3:30AM CDT
For traders with a short-term time horizon who are looking for big moves over a short period, we have updated our list of the 50 S&P 1500 stocks trading above $10 that have the largest intraday high-low ranges (based on the average percent spread...
CRR: 31.60 (-1.26), NBR: 15.04 (-0.53), BCEI: 24.79 (-0.22), LL: 33.07 (-0.58), PTEN: 21.16 (-0.60), MNTA: 20.13 (+0.04), HOS: 20.56 (-0.22), KOP: 22.47 (+0.03), DO: 29.82 (-0.58), BBG: 10.01 (-0.12), SGY: 16.48 (-0.23), FTK: 14.06 (-0.43), SPN: 23.61 (-0.63), ROVI: 19.48 (+0.18), WPX: 13.19 (-0.14), AKRX: 55.24 (-0.68), MCF: 21.86 (+0.27), ZEUS: 11.52 (+0.04), LGND: 89.75 (+0.83), DEPO: 27.65 (+0.36), CCRN: 11.60 (+0.07), ESV: 24.04 (-0.23), ANIP: 70.26 (-1.52), SGNT: 25.20 (-0.40), PDCE: 55.50 (-0.47), NE: 15.67 (-0.40), UIHC: 21.02 (+0.03), TNGO: 14.32 (-0.10), SGMS: 12.80 (+0.20), GIFI: 14.36 (-0.98), TDW: 24.40 (-1.03), CENX: 13.04 (+0.10), UNT: 30.09 (-0.60), RIG: 16.40 (-0.57), SPOK: 20.91 (-0.03), GPRE: 31.77 (+0.44), SYRG: 12.39 (+0.01), GEOS: 21.09 (-0.48), CBM: 42.97 (+0.37), SM: 54.36 (-0.95), TESO: 12.59 (-0.24), ROSE: 22.13 (-0.16), RGEN: 34.75 (-0.25), VDSI: 25.64 (-0.39), SKYW: 14.04 (+0.23), GLF: 13.58 (-0.05), SLCA: 34.70 (-1.30), RDC: 19.26 (-0.28), EHTH: 13.50 (+2.06)
Akorn Leads Top Generic-Drug Stocks, Nears Buy Point
at Investor's Business Daily - Mon Apr 20, 5:06PM CDT
The generic-drug group was ranked No. 2 out of the 197 industries tracked by IBD on Monday, so it's little wonder that three of its members made the 16-stock Spotlight screen. Akorn (AKRX), arguably the top stock in the industry, is nearing a 55.96...
MNK: 122.01 (-2.84), LCI: 67.40 (unch), AKRX: 55.24 (-0.68)
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Akorn, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 4, 2015 -- AKRX
GlobeNewswire - Mon Apr 20, 4:55PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
AKRX: 55.24 (-0.68)